By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer On March 24, 2025, Imunon, Inc. (NASDAQ:IMNN) announced it reached alignment with the U.S. FDA on the protocol for a Phase 3 clinical trial, referred to as OVATION 3, of … Read more
Matteo Zamboni (human rights lawyer working between Italy and the UK. He is a partner to the Immigration Law and Policy clinic of Goldsmiths, University of London) Photo: The towers of the Court of Justice in the Luxembourg fog (c) Matteo Zamboni On Tuesday 25 February 2025 I attended the Grand Chamber … Read more
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Reaches Alignment with FDA Regarding Phase 3 Trial Plan On November 25, 2024, Imunon, Inc. (NASDAQ:IMNN) announced it had reached alignment with the U.S. Food and Drug Administration (FDA) following an ‘End-of-Phase 2’ meeting on the company’s proposed plan for a Phase … Read more
Security Analysis of the MERGE Voting Protocol Interesting analysis: An Internet Voting System Fatally Flawed in Creative New Ways. Abstract: The recently published “MERGE” protocol is designed to be used in the prototype CAC-vote system. The voting kiosk and protocol transmit votes over the internet and then transmit voter-verifiable paper ballots through the mail. In … Read more